KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Capital Leases (2020 - 2025)

Novavax has reported Capital Leases over the past 9 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Capital Leases at $2.1 million for Q4 2025, down 96.11% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (down 96.11% YoY), and the annual figure for FY2025 was $2.1 million, down 96.11%.
  • Capital Leases for Q4 2025 was $2.1 million at Novavax, down from $2.3 million in the prior quarter.
  • Over the last five years, Capital Leases for NVAX hit a ceiling of $55.9 million in Q4 2023 and a floor of $2.1 million in Q4 2025.
  • Median Capital Leases over the past 5 years was $41.9 million (2022), compared with a mean of $36.7 million.
  • Biggest five-year swings in Capital Leases: soared 79.02% in 2023 and later plummeted 96.11% in 2025.
  • Novavax's Capital Leases stood at $9.2 million in 2021, then skyrocketed by 239.8% to $31.2 million in 2022, then soared by 79.02% to $55.9 million in 2023, then fell by 3.93% to $53.7 million in 2024, then plummeted by 96.11% to $2.1 million in 2025.
  • The last three reported values for Capital Leases were $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $52.4 million (Q2 2025) per Business Quant data.